As per the research report, the Asia Pacific Cannula Market size is valued at USD 37.92 billion in 2022 and is estimated to be growing at a CAGR of 6.23% to reach USD 51.30 billion by 2027.
A cannula is a thin tube inserted in the vein or body cavity through which it is administered. PTFE tubing is mostly preferred because of its low rubbing and low maintenance acknowledgment of the human body. Cannula tubing is produced with clear PTFE or PTFE with added substances.
An increase in demand for minimally invasive procedures, an increase in mortality rate, and the cannula's requirement in every disease-related issue are growth contributing factors for the cannula market. Well, developed healthcare and infrastructure in the Asia Pacific region is a significant market driver. Technological advancements such as 3D printing and laser devices market-led market growth through the implementation of various new cannulas with a wide range of materials. Consumer awareness and availability of cannula, awareness, and early detection of diseases and healthy lifestyle concerns improved market size. The availability of silicone material for the cannula manufacturing process is a growth factor as silicone used cannula is mostly preferred by medical staff. It might not cause much pain during the insertion of a cannula into the vein. Major key players and investors are also growth factors for the APAC cannula market.
The medical devices industry's regulatory framework is uncertain, and hence this impacted market negatively. The primary concern for the cannula market is patient compliance. Many patients complain from having trouble with insertions of cannula inside the body into the vein. It might not hurt patients all the time when fitted in a place correctly, but there might be a problem carrying it to hand over time. For instance, patients who need to go under cancer therapy, viral infection discharge treatments have to keep cannula in the same place for a few days until the whole treatment plan is complete.
This research report on the Asia Pacific Cannula Market has been segmented and sub-segmented into the following categories:
Geographically, the Asia Pacific region has the third-largest market for cannula in the world by share. It is also the fastest-growing region in the world. Factors such as the rising number of surgical procedures and many patients are expected to drive market growth.
Asia Pacific region in the cannula market will witness the most considerable growth throughout the forecast period. Increased vulnerability in the spread of diseases, rise in the geriatric population, and rise in chronic diseases such as cancers, diabetes, cardiovascular diseases, and other diseases increase market size.
Governments' awareness programs for early detection of diseases and hospitalization plans and schemes, coverage of bills under countries' economic funds in the Asia Pacific region also augment factors for the market. India and China are the primary opportunities for the growing cannula market all over the Asia Pacific region and worldwide.
The Top companies leading in the APAC Cannula Market profiled in the report are Medtronic plc (U.S.), Edward Lifesciences Corp. (U.S.), Terumo Corporation (Japan), Sorin Group (Italy), and Maquet Holding B.V. & Co. KG (Germany), among others.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com